MAPK3 and melanoma: When B16 melanoma or LLC cells were treated with conditioned medium from lal−/− MSCs, decreased proliferation of tumor cells was observed (Figure 4A), accompanied by reduced activation of ERK1/2, p38MAPK, and STAT3 oncogenic molecules in tumor cells (Figure 4B and 4C).